Xt Cdx
Payments companies reported to CMS as associated with Xt Cdx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xt Cdx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xt Cdx
These are the largest totals companies reported as associated with Xt Cdx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jose Ortega | Lake Worth, FL | Hematology & Oncology | $751.24 |
| Miguel Araneo | Lake Worth, FL | Medical Oncology | $735.79 |
| Bobby Chawla | Caldwell, ID | Hematology & Oncology | $664.83 |
| Joel Lopez-Figueroa | Humacao, PR | Hematology & Oncology | $662.32 |
| Kirsten Stuber | Tyler, TX | Family | $653.92 |
| Heather Yeckes Rodin | Port St. Lucie, FL | Hematology & Oncology | $608.85 |
| Ashwin Mehta | Hollywood, FL | Sleep Medicine (Internal Medicine) | $605.86 |
| Fernando Recio | Boca Raton, FL | Hematology & Oncology | $599.63 |
| Guru Sonpavde | Orlando, FL | Medical Oncology | $577.01 |
| Oleg Gligich | Brooksville, FL | Hematology & Oncology | $560.92 |
Prescribed Xt Cdx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.